PRP vs Prolotherapy for Joint Pain: Explained by a Pain Specialist

Joint pain is a common clinical concern that affects individuals across different age groups, often arising from degenerative changes, prior injury or repetitive strain associated with daily activities. While symptoms may initially present as mild discomfort or stiffness, they can gradually progress to persistent pain that limits movement and affects functional ability.

Conventional management typically focuses on symptom control through medication, rest or physiotherapy. However, in cases where symptoms persist or recur, there is increasing interest in treatment approaches that aim to address the underlying tissue changes instead of providing temporary relief alone. This has led to growing attention towards regenerative techniques such as prolotherapy and platelet-rich plasma (PRP) therapy.

Although both treatments are frequently discussed in the context of joint pain, the distinction between them is not always clearly understood. Patients are often uncertain about how these therapies differ in mechanism, application and expected outcomes, which can make decision-making challenging.

This article provides a structured comparison of PRP and prolotherapy, outlining how each treatment works and how a pain specialist determines their role in the management of joint-related conditions.

What is joint pain and why does it persist?

Joint pain refers to discomfort arising from the structures within or surrounding a joint, including cartilage, ligaments, tendons and the joint lining [1]. It may occur as a result of injury, inflammation, or degenerative changes, and can affect both movement and joint stability.

In some cases, joint pain resolves once the underlying cause improves. However, it may persist when the affected tissues do not recover adequately. This can occur in conditions where there is ongoing degeneration, repeated mechanical stress or reduced capacity for tissue repair.

Persistent joint pain is often associated with structural changes within the joint, such as cartilage wear, ligament laxity or altered load distribution [2]. These changes can maintain irritation within the joint and contribute to recurring symptoms during normal activity.

Conventional treatments are typically directed at reducing pain and inflammation. While these approaches may provide short-term relief, they do not always address the underlying tissue changes, which is why symptoms may continue or return over time.

What is prolotherapy?

Prolotherapy is a minimally invasive treatment designed to stimulate the body’s natural healing response in areas of weakened or damaged tissue [3]. It is most commonly used for conditions involving ligaments, tendons and joint structures where instability or incomplete healing is present.

The treatment involves injecting a solution, typically a concentrated dextrose formulation, into the affected area. This solution acts as a mild irritant, triggering a controlled inflammatory response. In doing so, it encourages the body to initiate repair processes, including increased blood flow and the activation of healing pathways that strengthen the targeted tissue.

Prolotherapy is often considered in cases where joint pain is associated with ligament laxity, chronic strain or repetitive stress injuries. It is particularly relevant for patients whose symptoms persist despite conventional treatments, and where improving tissue stability is a key therapeutic goal.

What is PRP (Platelet-Rich Plasma) therapy?

Platelet-rich plasma (PRP) therapy is a regenerative treatment that uses components derived from the patient’s own blood to support tissue healing [4]. It is based on the principle that platelets contain growth factors that play a central role in the body’s natural repair processes.

The procedure involves drawing a small sample of blood, which is then processed to concentrate the platelets. This platelet-rich solution is subsequently injected into the affected area under controlled conditions. Once introduced into the tissue, the growth factors released by the platelets help stimulate cellular activity, promote repair and support regeneration.

PRP is commonly used in conditions involving tendon injuries, ligament damage and degenerative joint changes, including early osteoarthritis [5]. It is often considered when there is a need to enhance healing in tissues that have limited natural regenerative capacity.

Compared to prolotherapy, PRP is generally regarded as a more biologically targeted approach, as it delivers concentrated healing factors directly to the site of injury [6]. Its role is not to induce irritation, but to amplify the body’s existing repair mechanisms in a more focused manner.

Key differences between PRP (Platelet-Rich Plasma) therapy and Prolotherapy

PRP and prolotherapy are both used in the management of joint pain with the aim of supporting tissue repair rather than simply reducing symptoms. While they share a similar goal, they differ in how they are prepared, how they work and the type of response they produce in the body.

Understanding these differences is important when considering which approach may be more appropriate, as the choice often depends on the nature of the condition, the extent of tissue damage and the desired treatment outcome.

Which treatment is more effective for joint pain?

There is no single treatment that works best for all types of joint pain. The choice between prolotherapy and PRP depends on the underlying cause, the extent of tissue involvement, and how long the symptoms have been present. Each treatment has a specific role, and effectiveness is closely linked to selecting the right approach for the condition.

Key factors that influence which treatment may be more effective include:

• Severity of joint damage — in milder cases, such as early ligament strain or minor joint instability, prolotherapy is often sufficient to stimulate healing and improve support around the joint [7]. These conditions typically do not require a strong biological intervention. In contrast, when there is more advanced degeneration or structural change, PRP may be preferred as it delivers a higher concentration of growth factors to support repair [8].
• The type of tissue involved — different tissues respond differently to treatment. Prolotherapy is commonly used when the goal is to improve ligament strength and joint stability, particularly in cases of laxity or repetitive strain [9]. PRP is more often considered when tendons or cartilage are involved, as it provides a more targeted biological effect that supports tissue regeneration [10].
• Duration of symptoms — recent or short-term symptoms may respond well to prolotherapy, especially when the issue is related to strain or instability. However, when symptoms have been present for a longer period, the tissue’s natural healing response may be reduced. In such cases, PRP may be more appropriate as it helps stimulate repair in tissues that are slower to heal.
• Healing response required — prolotherapy works by triggering a controlled inflammatory response, encouraging gradual tissue repair over time. This makes it suitable for conditions where repeated stimulation can improve tissue strength. PRP, on the other hand, introduces concentrated growth factors directly into the affected area, producing a more focused and potentially stronger healing response.

In sum, prolotherapy is often considered for mild to moderate instability or soft tissue strain, while PRP is more commonly used for chronic, degenerative or slower-healing conditions. The most appropriate treatment is best determined through a detailed clinical assessment rather than a fixed preference for one option.

What conditions can PRP and prolotherapy treat?

PRP and prolotherapy are both used to manage a range of musculoskeletal conditions, particularly those involving joint pain, soft tissue strain and instability. There is often overlap in the conditions they treat, but the choice between them depends on the severity of tissue damage, the type of structure involved, and how long the symptoms have been present.

Common conditions where these treatments may be considered include:

• Knee osteoarthritis — both PRP and prolotherapy are used in the management of early to moderate knee osteoarthritis. Prolotherapy may help improve joint stability and reduce strain on surrounding structures in milder cases. PRP is more commonly considered when there is cartilage degeneration, as it provides a stronger biological stimulus aimed at supporting joint tissue repair.
• Shoulder pain (rotator cuff issues)  — conditions affecting the rotator cuff, such as tendinopathy or partial tears, may be treated with either approach. Prolotherapy may be used where ligament support or mild tendon strain is the primary issue. PRP is often preferred in more persistent cases or where tendon healing is limited, as it delivers concentrated growth factors directly to the affected tissue.
• Tennis elbow and golfer’s elbow — both treatments are used for chronic elbow tendinopathy. Prolotherapy may be effective in earlier or less severe cases by stimulating a gradual healing response. PRP is often considered in long-standing or treatment-resistant cases, where a more targeted regenerative approach is needed.
• Ligament injuries — prolotherapy is commonly used for ligament laxity or partial injury, particularly when the goal is to improve joint stability over time. PRP may be used in more significant injuries or where healing has been slow, especially if there is associated tendon involvement.
• Chronic joint instability — in cases where joints feel loose or repeatedly symptomatic, prolotherapy is often the first consideration as it aims to strengthen supporting ligaments. PRP may be introduced in more complex or persistent cases where tissue healing needs to be enhanced further.

Are PRP and prolotherapy safe?

PRP and prolotherapy are generally considered safe when performed by a trained and experienced practitioner, as both are minimally invasive procedures designed to support tissue healing. PRP uses a patient’s own blood (autologous source), which reduces the risk of allergic reactions or rejection, making it well tolerated in most individuals. Prolotherapy has also been used for many years and is regarded as a well-established technique, although outcomes depend on appropriate patient selection and injection accuracy [11].

As with any injection-based treatment, there may be mild and temporary side effects following the procedure. These commonly include localised pain, swelling or stiffness at the injection site, which usually settles within a few days. More significant complications are uncommon when the procedure is performed under proper clinical guidance.

The safety and effectiveness of both treatments are closely linked to the expertise of the practitioner. Careful assessment, accurate diagnosis and the use of image-guided techniques where appropriate help ensure that the treatment is delivered safely and to the correct target area.

What should patients expect during treatment?

Both PRP and prolotherapy follow a similar overall process, although the preparation and number of sessions may differ. Treatment typically begins with a detailed consultation, where the underlying cause of joint pain is assessed through clinical evaluation and, where needed, imaging studies. This step is important to ensure that the injection is directed at the correct structure.

The procedure itself involves targeted injections into the affected area. In PRP, a small sample of the patient’s blood is first drawn and processed before being injected. In prolotherapy, a prepared solution is injected directly into the area of concern. Image guidance may be used to improve accuracy, particularly in deeper or more complex joints.

Most patients can return home on the same day, although some temporary discomfort or soreness at the injection site is expected. Activity may need to be modified for a short period, especially avoiding excessive strain on the treated joint. The number of sessions varies depending on the condition, with prolotherapy often requiring a series of treatments, while PRP may require fewer sessions in selected cases.

It is important to note that improvement is usually gradual, as these treatments aim to support the body’s healing process, and symptom relief typically develops over weeks. 

PRP vs prolotherapy: which one should you choose?

Choosing between PRP and prolotherapy is not a matter of one treatment being better than the other. The decision depends on the underlying condition, the type of tissue involved, and the overall treatment goals.

A personalised assessment is essential to determine the most appropriate option. Factors such as the severity of joint damage, the duration of symptoms and previous response to treatment all play a role in guiding this decision. Imaging studies may also be used to better understand the extent of structural changes and to support treatment planning.

In clinical practice, both treatments may be used at different stages of care or even as part of a combined approach, depending on the patient’s needs. The role of a pain specialist is to identify the source of the problem and recommend a treatment strategy that aligns with the specific condition rather than applying a one-size-fits-all approach.

When should you consider these treatments?

PRP and prolotherapy are typically considered when joint pain persists despite initial conservative measures or when symptoms begin to affect daily function.

They may be appropriate in the following situations:

• Persistent joint pain despite conservative care — when symptoms continue despite medication, rest or physiotherapy, further treatment may be needed to address the underlying issue.
• Avoiding or delaying surgery — these treatments are often considered by individuals who wish to explore non-surgical options before proceeding to more invasive interventions.
• Recurrent injuries or joint instability — repeated strain or instability may indicate underlying tissue weakness that requires targeted treatment.
• Reduced function affecting daily life — difficulty with movement, exercise or routine activities may suggest that symptoms are progressing and require further evaluation.

Conclusion 

PRP and prolotherapy represent two distinct approaches within the broader shift towards treatments that aim to support tissue healing rather than simply control symptoms. While both are used in the management of joint pain, they differ in their mechanism, biological effect and clinical application. Understanding these differences is important, as the effectiveness of each treatment depends on how well it aligns with the underlying condition.

Joint pain is rarely uniform in its cause or progression. Factors such as tissue type, severity of damage and duration of symptoms all influence how the body responds to treatment. In this context, neither PRP nor prolotherapy should be viewed as a universal solution. Instead, they are tools that may be used selectively, based on a careful assessment of the individual’s condition.

A structured evaluation, supported by clinical examination and, where appropriate, imaging, allows for a more targeted approach to treatment. This ensures that the chosen intervention addresses not only the symptoms, but also the underlying factors contributing to ongoing pain.

If you are experiencing persistent joint pain and would like to explore whether PRP or prolotherapy is suitable for your condition, schedule a consultation with Total Pain Specialist for a personalised assessment and treatment plan.

References 

1. Joint pain: Many joints – bone, joint, and muscle disorders. (n.d.). MSD Manual Consumer Version. Retrieved March 27, 2026, from https://www.msdmanuals.com/home/bone-joint-and-muscle-disorders/symptoms-of-musculoskeletal-disorders/joint-pain-many-joints 
2. Fleming, B. C., Hulstyn, M. J., Oksendahl, H. L., & Fadale, P. D. (2005). Ligament injury, reconstruction and osteoarthritis. Current Opinion in Orthopaedics, 16(5), 354–362. https://doi.org/10.1097/01.bco.0000176423.07865.d2 
3. Bae, G., Kim, S., Lee, S., Lee, W. Y., & Lim, Y. (2021). Prolotherapy for the patients with chronic musculoskeletal pain: Systematic review and meta-analysis. Anesthesia and Pain Medicine, 16(1), 81–95. https://doi.org/10.17085/apm.20078 
4. Pavlovic, V., Ciric, M., Jovanovic, V., & Stojanovic, P. (2016). Platelet Rich Plasma: A short overview of certain bioactive components. Open Medicine, 11(1), 242–247. https://doi.org/10.1515/med-2016-0048 
5. Halpern, B. C., Chaudhury, S., & Rodeo, S. A. (2012). The role of platelet-rich plasma in inducing musculoskeletal tissue healing. HSS Journal, 8(2), 137–145. https://doi.org/10.1007/s11420-011-9239-7 
6. Goh, S.-L., Jaafar, Z., Gan, Y.-N., Choong, A., Kaur, J., Kundakci, B., Abdul Karim, S., Jaffar, M. R., & A. Hamid, M. S. (2021). Efficacy of prolotherapy in comparison to other therapies for chronic soft tissue injuries: A systematic review and network meta-analysis. PLoS ONE, 16(5), e0252204. https://doi.org/10.1371/journal.pone.0252204 
7. Zhao, A. T., Caballero, C. J., Nguyen, L. T., Vienne, H. C., Lee, C., & Kaye, A. D. (n.d.). A comprehensive update of prolotherapy in the management of osteoarthritis of the knee. Orthopedic Reviews, 14(3), 33921. https://doi.org/10.52965/001c.33921 
8. Everts, P., Onishi, K., Jayaram, P., Lana, J. F., & Mautner, K. (2020). Platelet-rich plasma: New performance understandings and therapeutic considerations in 2020. International Journal of Molecular Sciences, 21(20), 7794. https://doi.org/10.3390/ijms21207794 
9. Rabago, D., Slattengren, A., & Zgierska, A. (2010). Prolotherapy in primary care practice. Primary Care, 37(1), 65–80. https://doi.org/10.1016/j.pop.2009.09.013 
10. Saad, R., Ghanem, W., Ezzeddine, H., Assaf, F., Kiwan, E., Al Fakih, O., Badra, M., & Moucharafieh, R. (n.d.). Platelet-rich plasma therapy in treating tendon injuries of the hand: A narrative review. Orthopedic Reviews, 17, 147173. https://doi.org/10.52965/001c.147173 
11. Mociu, S.-I., Nedelcu, A.-D., Lupu, A.-A., Uzun, A.-B., Iliescu, D.-M., Ionescu, E.-V., & Iliescu, M.-G. (2025). Prolotherapy as a regenerative treatment in the management of chronic low back pain: A systematic review. Medicina, 61(9), 1588. https://doi.org/10.3390/medicina61091588